Role of cell cycle regulators in lung carcinogenesis

被引:89
作者
Eymin, Beatrice
Gazzeri, Sylvie [1 ]
机构
[1] Inst Albert Bonniot, Equipe Bases Mol Progress Canc Poumon, Ctr Rech, INSERM,U823, Grenoble, France
关键词
lung cancer; cell cycle regulators; kinases; checkpoint; therapy;
D O I
10.4161/cam.4.1.10977
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cellular division is an ordered, tightly regulated process involving multiple checkpoints that assess extracellular growth signals, cell size and DNA integrity. Progression throughout the cell cycle is based on the activation of different CDK-cyclin complexes that prevent cells from entering into a new phase until thay have successfully complete the previous one. In addition, a series of cell cycle checkpoints are designed to preserve genome integrity and chromosomal stability. Neoplastic lung cells develop the ability to bypass several of these checkpoints, and tumor cell proliferation is frequently associated with genetic or epigenetic alterations in key regulators of the cell cycle. The goal of this review is to summarize the knowledge about the dysregulation of major cell cycle regulators in lung cancer pathogenesis and to discuss the use of these proteins as targets for therapeutic intervention.
引用
收藏
页码:114 / 123
页数:10
相关论文
共 124 条
[1]   Polo-like kinases: conservation and divergence in their functions and regulation [J].
Archambault, Vincent ;
Glover, David M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2009, 10 (04) :265-275
[2]  
Arinaga M, 2003, ONCOL REP, V10, P1381
[3]   Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation [J].
Babu, JR ;
Jeganathan, KB ;
Baker, DJ ;
Wu, XS ;
Kang-Decker, N ;
van Deursen, JM .
JOURNAL OF CELL BIOLOGY, 2003, 160 (03) :341-353
[4]  
Baldi A, 1996, CLIN CANCER RES, V2, P1239
[5]  
Baldi A, 1997, CLIN CANCER RES, V3, P1691
[6]   Aurora-A: the maker and breaker of spindle poles [J].
Barr, Alexis R. ;
Gergely, Fanni .
JOURNAL OF CELL SCIENCE, 2007, 120 (17) :2987-2996
[7]   Polo-like kinases and the orchestration of cell division [J].
Barr, FA ;
Silljé, HHW ;
Nigg, EA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (06) :429-440
[8]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[9]   Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[10]   A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days [J].
Benson, C. ;
White, J. ;
De Bono, J. ;
O'Donnell, A. ;
Raynaud, F. ;
Cruickshank, C. ;
McGrath, H. ;
Walton, M. ;
Workman, P. ;
Kaye, S. ;
Cassidy, J. ;
Gianella-Borradori, A. ;
Judson, I. ;
Twelves, C. .
BRITISH JOURNAL OF CANCER, 2007, 96 (01) :29-37